Alexa Israeli
Athens, OHNPI 1689314775
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,811 of the $12,307 with a category attached, or 87.8%. It is spread thinly across 29 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,671, more than ten times the $335 reported in 2023.
Across 176 payments — averaging $69.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$2K
- Sanofi$2K
- AbbVie$1K
- Johnson & Johnson$815
- UCB, Inc.$742
- Novartis$696
- plus $5K from 23 others
What the payments were for
- Consulting fees$1,1039%
- Food & beverage$10,81188%
- Education$3933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 8 | $1,994 |
| Sanofi | 26 | $1,535 |
| AbbVie | 11 | $1,053 |
| Johnson & Johnson | 26 | $815 |
| UCB, Inc. | 9 | $742 |
| Novartis | 14 | $696 |
| Incyte Corporation | 14 | $662 |
| Lilly USA, LLC | 8 | $567 |
| Arcutis Biotherapeutics, Inc. | 5 | $414 |
| Regeneron Healthcare Solutions, Inc. | 7 | $380 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $346 |
| Boehringer Ingelheim | 6 | $340 |
| Dermavant Sciences, Inc. | 4 | $330 |
| Almirall LLC | 3 | $323 |
| Kyowa Kirin, Inc. | 4 | $248 |
| Biofrontera Inc. | 7 | $237 |
| Journey Medical Corporation | 3 | $204 |
| Sun Pharmaceutical Industries Inc. | 4 | $196 |
| Merz North America, Inc. | 1 | $194 |
| Pfizer | 2 | $171 |
| Galderma Laboratories, L.p. | 2 | $149 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Blueprint Medicines Corporation | 1 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $119 |
| Sanofi US Services Inc. | 1 | $116 |
| Organon | 1 | $107 |
| Sandoz | 1 | $83 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.